LOINC display name : Fatty acid omega-3 and omega-6 panel;
LOINC long common name : Fatty acid omega-3 and omega-6 panel - Serum or Plasma;
LOINC short name : FA omega-3 omega-6 panel SerPl;
LOINC description : The terms in this panel are used to monitor the omega-3 and omega-6 levels of patients
with known cardiovascular disease and who are on supplemental therapy with omega-3/omega-6
supplements or being evaluated to receive it. Early data suggests healthy levels of
omega-3 and omega-6 could have positive health outcomes on patients with age-related
macular degeneration, rheumatoid arthritis, cancer and others. Relative intake of
omega-6s and omega-3s (omega-6/omega-3) is believed by some researchers to gauge the
impact of the development of some chronic diseases including cardiovascular disease
and cancer, but no ideal ratio has been determined. Similarly, no normal ranges have
been defined for serum or plasma phospholipid omega 3s, reported as the percentage
of total phospholipid fatty acids by weight. EPA and DHA can be measured as the percentage
of total erythrocyte fatty acids and is referred to as the omega-3 index. The omega-3
index is typically 3-5% in individuals living in Western countries that have a low
intake of fish in their diet. [https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/];
Has component